Revenue (Quarterly) Chart

View Revenue (Quarterly) for ETST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 9.026M
March 31, 2026 9.498M
December 31, 2025 8.387M
September 30, 2025 9.051M
June 30, 2025 8.760M
March 31, 2025 8.677M
December 31, 2024 7.353M
September 30, 2024 8.519M
June 30, 2024 8.569M
March 31, 2024 6.016M
December 31, 2023 3.790M
September 30, 2023 1.928M
June 30, 2023 0.2199M
March 31, 2023 0.046M
December 31, 2022 0.0025M
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.0002M
December 31, 2021 0.004M
September 30, 2021 0.0025M
June 30, 2021 0.0075M
March 31, 2021 0.0183M
December 31, 2020 0.0239M
September 30, 2020 0.0266M
June 30, 2020 0.0721M
Date Value
March 31, 2020 0.0614M
December 31, 2019 0.0974M
September 30, 2019 0.1396M
June 30, 2019 0.2276M
March 31, 2019 0.1997M
December 31, 2018 0.2028M
September 30, 2018 0.2013M
June 30, 2018 0.1669M
March 31, 2018 0.1717M
December 31, 2017 0.1009M
September 30, 2017 0.0892M
June 30, 2017 0.1013M
March 31, 2017 0.1196M
December 31, 2016 0.1092M
September 30, 2016 0.0825M
June 30, 2016 0.1408M
March 31, 2016 0.0984M
December 31, 2015 0.174M
September 30, 2015 0.1154M
June 30, 2015 0.0816M
March 31, 2015 0.0593M
December 31, 2014 0.0143M
September 30, 2014 0.0066M
June 30, 2014 0.00
March 31, 2014 0.00

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Resonate Blends, Inc. 0.2424M
Breakthrough Chemistry, Inc. 0.0025M
Kaya Holdings, Inc. 0.0054M
Cardiac Biotech Solutions, Inc. 0.0402M
Endexx Corp. 0.0032M